Using artificial intelligence to improve diagnosis of irritable bowel syndrome
Part of Digestive system clinical trials.
This study uses a special microscope during a colonoscopy to take detailed pictures of your gut lining. An artificial intelligence (AI) program will learn from these pictures to help doctors better diagnose irritable bowel syndrome (IBS).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a confirmed diagnosis of IBS based on the Rome IV criteria (recurring belly pain for at least 6 months, with changes in bowel habits).
- You are willing to undergo a special type of colonoscopy using a tiny microscope probe (called pCLE) to look at your gut lining.
- You have normal blood clotting and can safely have small tissue samples (biopsies) taken during the procedure.
- You do not have allergies to fluorescein dye, and you are not pregnant, breastfeeding, or have certain serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.
This study looks at the bacteria in your gut (microbiome) and how they relate to your IBS symptoms. It may help researchers understand IBS better and could lead to new treatments.
This study looks at whether a simple test can help doctors tell the difference between conditions that cause long-term gut problems, like irritable bowel syndrome (a functional disorder) and inflammatory bowel disease (a disease that causes inflammation). It aims to find a way to diagnose without invasive procedures, which could lead to faster and more comfortable diagnosis for patients.
This study compares the bacteria and natural chemicals in the intestines of people with irritable bowel syndrome (IBS) to those without it. It aims to find differences that could help improve IBS diagnosis or treatment.
This trial uses artificial intelligence to help doctors better identify and pinpoint where they are in your colon during a colonoscopy. It may improve the accuracy of the procedure.
This trial uses artificial intelligence to combine CT/MR scans and colonoscopy images to better diagnose and predict outcomes for people with inflammatory bowel disease, intestinal tuberculosis, or Behçet's disease. It aims to see if AI can help doctors make more accurate decisions.
Hear when a new Irritable Bowel Syndrome (IBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.